36,442 research outputs found
Highly accurate model for prediction of lung nodule malignancy with CT scans
Computed tomography (CT) examinations are commonly used to predict lung
nodule malignancy in patients, which are shown to improve noninvasive early
diagnosis of lung cancer. It remains challenging for computational approaches
to achieve performance comparable to experienced radiologists. Here we present
NoduleX, a systematic approach to predict lung nodule malignancy from CT data,
based on deep learning convolutional neural networks (CNN). For training and
validation, we analyze >1000 lung nodules in images from the LIDC/IDRI cohort.
All nodules were identified and classified by four experienced thoracic
radiologists who participated in the LIDC project. NoduleX achieves high
accuracy for nodule malignancy classification, with an AUC of ~0.99. This is
commensurate with the analysis of the dataset by experienced radiologists. Our
approach, NoduleX, provides an effective framework for highly accurate nodule
malignancy prediction with the model trained on a large patient population. Our
results are replicable with software available at
http://bioinformatics.astate.edu/NoduleX
Recommended from our members
Artificial intelligence approaches to predicting and detecting cognitive decline in older adults: A conceptual review.
Preserving cognition and mental capacity is critical to aging with autonomy. Early detection of pathological cognitive decline facilitates the greatest impact of restorative or preventative treatments. Artificial Intelligence (AI) in healthcare is the use of computational algorithms that mimic human cognitive functions to analyze complex medical data. AI technologies like machine learning (ML) support the integration of biological, psychological, and social factors when approaching diagnosis, prognosis, and treatment of disease. This paper serves to acquaint clinicians and other stakeholders with the use, benefits, and limitations of AI for predicting, diagnosing, and classifying mild and major neurocognitive impairments, by providing a conceptual overview of this topic with emphasis on the features explored and AI techniques employed. We present studies that fell into six categories of features used for these purposes: (1) sociodemographics; (2) clinical and psychometric assessments; (3) neuroimaging and neurophysiology; (4) electronic health records and claims; (5) novel assessments (e.g., sensors for digital data); and (6) genomics/other omics. For each category we provide examples of AI approaches, including supervised and unsupervised ML, deep learning, and natural language processing. AI technology, still nascent in healthcare, has great potential to transform the way we diagnose and treat patients with neurocognitive disorders
- …